Literature DB >> 20031835

Hazard function and secular trends in the risk of recurrent acute myocardial infarction: 30 years of follow-up of more than 775,000 incidents.

Mats Gulliksson1, Hans Wedel, Max Köster, Kurt Svärdsudd.   

Abstract

BACKGROUND: The incidence of a first acute myocardial infarction (AMI) has fallen considerably during the last decades. However, no previous studies have analyzed the underlying hazards function of experiencing a recurrent AMI, and none has analyzed the change of risk for a recurrent AMI over the last 3 decades. METHODS AND
RESULTS: The study was based on the Swedish national myocardial infarction register. The register contained more than 1 million AMI events. After exclusion of events occurring in subjects younger than 20 or older than 84 years and events with uncertain first AMI status, 775 901 events occurring between 1972 and 2001 remained for analysis. During the study period, the risk of a new event among survivors of a previous AMI decreased sharply during the first 2 years after the previous event, had its minimum after 5 years, and then increased slowly again. The risk for a recurrent AMI during the first year after a previous event was fairly stable over the years until the late 1970s and then decreased by 36% in women and 40% in men until the late 1990s, irrespective of age and AMI number, mirroring the incidence decrease over the years for primary events.
CONCLUSIONS: The risk of a recurrent AMI event was highly dependent on time from the previous event, a novel finding which may affect risk scoring. There were strong secular trends toward diminishing risk for a recurrent AMI in recent years, even when other outcome affecting variables were taken into account.

Entities:  

Mesh:

Year:  2009        PMID: 20031835     DOI: 10.1161/CIRCOUTCOMES.108.802397

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  7 in total

1.  The changing epidemiology of myocardial infarction in Olmsted County, Minnesota, 1995-2012.

Authors:  Yariv Gerber; Susan A Weston; Ruoxiang Jiang; Véronique L Roger
Journal:  Am J Med       Date:  2014-09-28       Impact factor: 4.965

2.  Cardiovascular disease occurrence in two close but different social environments.

Authors:  Carina Wennerholm; Björn Grip; Annakarin Johansson; Hans Nilsson; Marja-Liisa Honkasalo; Tomas Faresjö
Journal:  Int J Health Geogr       Date:  2011-01-12       Impact factor: 3.918

3.  Initiation and persistence with dual antiplatelet therapy after acute myocardial infarction: a Danish nationwide population-based cohort study.

Authors:  Anders Green; Anton Pottegård; Anne Broe; Thomas Goldin Diness; Martha Emneus; Pål Hasvold; Gunnar H Gislason
Journal:  BMJ Open       Date:  2016-05-12       Impact factor: 2.692

Review 4.  Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era.

Authors:  Umberto Barbero; Fabrizio D'Ascenzo; Freek Nijhoff; Claudio Moretti; Giuseppe Biondi-Zoccai; Marco Mennuni; Davide Capodanno; Marco Lococo; Michael J Lipinski; Fiorenzo Gaita
Journal:  Scientifica (Cairo)       Date:  2016-04-27

Review 5.  Prognostic Value of Circulating Inflammatory Cells in Patients with Stable and Acute Coronary Artery Disease.

Authors:  John A L Meeuwsen; Marian Wesseling; Imo E Hoefer; Saskia C A de Jager
Journal:  Front Cardiovasc Med       Date:  2017-07-14

6.  National trends in recurrent AMI hospitalizations 1 year after acute myocardial infarction in Medicare beneficiaries: 1999-2010.

Authors:  Sarwat I Chaudhry; Rabeea F Khan; Jersey Chen; Kumar Dharmarajan; John A Dodson; Frederick A Masoudi; Yun Wang; Harlan M Krumholz
Journal:  J Am Heart Assoc       Date:  2014-09-23       Impact factor: 5.501

7.  Trends in Acute Myocardial Infarction by Race and Ethnicity.

Authors:  Gloria C Chi; Michael H Kanter; Bonnie H Li; Lei Qian; Stephanie R Reading; Teresa N Harrison; Steven J Jacobsen; Ronald D Scott; Jeffrey J Cavendish; Jean M Lawrence; Sara Y Tartof; Kristi Reynolds
Journal:  J Am Heart Assoc       Date:  2020-03-02       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.